COVID: SHABIR MADHI, PROFESSOR WHO LED STUDY IN SOUTH AFRICA ON OXFORD VACCINE, SAYS WE THINK THERE IS STILL SOME HOPE THAT IT WILL WORK AS WELL AS JOHNSON & JOHNSON ON SEVERE DISEASE

PUBLISHED: Mon, 08 Feb 2021 08:16:36 GMT
Share

COVID: SHABIR MADHI, PROFESSOR WHO LED STUDY IN SOUTH AFRICA ON OXFORD VACCINE, SAYS WE THINK THERE IS STILL SOME HOPE THAT IT WILL WORK AS WELL AS JOHNSON & JOHNSON ON SEVERE DISEASE

Sign Up for Our Newsletter Daily Update

Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.

(c) Copyright Thomson Reuters 2021. Click For Restrictions – https://agency.reuters.com/en/copyright.html